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Techniques for determining efficacy of different anticoccidia drugs on the growth and development of the
camelid parasite, Eimeria macusaniensis, in cell cultures
Daniel Houlihan
Abstract
Eimeria macusaniensis, a coccidian parasite, continues to be a threat to New World
Camelids (NWCs) in the United States because there are no current proven methods of
treatment. This internal parasite is a major cause of diarrhea in NWCs, invading the small
intestine of NWCs and increasing the susceptibility for secondary bacterial and viral
infections. Clinical signs of infected animals range from mild diarrhea and decreased
appetite to death. Currently used treatment protocols for E. macusaniensis coccidisosis in
llamas and alpacas have been extracted from those used to treat non-camelid species
against coccidian, as data and validated treatment protocols in NWCs are lacking. This
research project studied the life cycle of E.macusaniensis in a laboratory setting by
examining and modifying various techniques used to detect, concentrate, and sporulate
E.macusaniensis oocysts for use in future research projects. The new protocols and
modifications developed in this project will lay the foundation for a later project in which
infectious sporozoites obtained from sporulated E.macusaniensis will be inoculated in vetro
in Vero-cell cultures. Once inoculated, the infected cultures will be subjected to a drug
dosing assay of various anti-protozoal drugs to test the efficacy of the drugs on the
destruction of the parasite. The completion of this project provides enough evidence to
support further in vivo/vetro testing in the treatment of E.macusaniensis in llamas and
alpacas.
Eimeria macusaniensis is a protozoal
parasite of the Phylum Apicomplexa that
causes fatal enteritis in New World camelids
(NWCs) worldwide (Rickard 1994;
Lenghaus, O’Callaghan et al. 2004; Cebra,
Valentine et al. 2007). Infected animals will
shed oocyts in manure, which eventually
sporulate in the proper environmental
conditions. These infective sporozoites are
then taken up by other foraging NWCs and
continue the life cycle in the small intestine
of the host. Infectious sporozoites invade
host cells and form merozoites through an
internal fission process called schizogony.
Oocysts are released by rupture of the host

cell and pass into the feces (Bowman).
Because the majority of intestinal damage
occurs prior to shedding oocysts, disease
and clinical signs can be apparent before
oocysts are even detected in feces. In most
instances, a healthy adult animal with a mild
infection of E.macusaniensis will rarely
demonstrate clinical signs of infection.
However, in immuno-compromised, young,
old or severely infected animals, infections
are associated with lethargy, anorexia,
weight loss, sudden death and hemorrhagic
diarrhea (Ballweber 2009).
E.macusaniensis may measure up to
twice the size of other NWC specific

Eimeria, measuring 93.6 µm by
67.4 µm compared to a range of
30-60 µm by 30-40 µm of other
Eimeria. This large size variance
can lead to severe clinic signs even
in healthy animals (Cafrune et al.
2009). Unlike most coccidian in
which infection is limited to one
hosts, E.macusaniensis has been
shown to effect all four NWC
species (llamas, alpacas, vicunas
and guanacos) (Leguia
1991;Beldomenico, Uhart et al.
2003). Due to its large size, it is
more likely to result in devastating
secondary bacterial and viral
infections in the small intestine.
These secondary infections cause
the animal to experience moderate
Figure 1: E.macusaniensis compared to a typical
to severe diarrhea and can often lead to
gastro-intestinal nematode egg (GIN)
death after exhibiting clinical signs for only
a few days. Since E.macusaniensis could
pose a large threat to farmers in the United
States (especially in the Midwest), a
successful and effective form of treatment is
vital. This paper will explore various
protocols for the steps involved in producing
viable and infectious E.macusaniensis for
use in Vero-cell cultures.
Materials and Methods
In order to produce infectious
E.macusaniensis sporozoites, a constant
supply of viable occysts needed to be
obtained. Initially, samples of fresh llama
and alpaca feces were evaluated for the
presence of E.macusaniensis from various
farms in Virginia and Tennessee (Kinser and
Dreamland Farms) over the years 2008-2009.
Samples were collected by herd owners,
shipped chilled and examined within one
week of arrival at the University of
Tennessee College of Veterinary Medicine
Parasitology Diagnostics Laboratory. Fecal
samples were stored in zip-lock bags at 34°C when not being used. In order to test

for the presence of E.macusaniensis, 1-2
grams of a sample were mixed with 15 ml of
distilled water. The solution was filtered
through 2-layers of grade #50 cheesecloth
(approximate filtration of 100 µm), placed
into a 15 ml centrifuge tube, and centrifuged
at 1500 rpm for 5 minutes. The supernatant
was decanted and discarded without
disturbing the pellet. The pellet was then
reconstituted and mixed with Sheather’s
Sugar Solution (spg. 1.275) and filled to the
top (slight meniscus present). A cover slip
was placed onto the centrifuge tube and it
was centrifuged at the above conditions.
Upon completion, the sample was examined

E.macusaniensis in
Potassium Dichromate 9
days showing invagination

E.macusaniensis in
Potassium Dichromate 1
week

E.macusaniensis in Potassium
Dichromate 21 days full
sporulation

Infection if ingested

E.macusaniensis in Potassium
Dichromate 12 days
demonstrating four distinct
quadrants

E.macusaniensis in Potassium
Dichromate 19 days partial
sporulation

under a microscope at 100x power to check
for the presence of E.macusaniensis.
Unfortunately, a lack of positive
samples (approximately 2 cases out of 100)
from farms on the East Coast temporarily
impeded research efforts. To ensure a
constant supply of E.macusaniensis, two
llamas were obtained from a local stock
sale for use in this project. The llamas,
(estimated age approximately 3 years) were
housed at the East Tennessee Clinical
Research Center in individual stalls under
constant veterinary care. Upon
examination using the methods listed above,
it was discovered that one of the llamas had
a pre-existing E.macusaniensis infection.
Samples from this llama were collected
every 1-3 days and stored at 3-4°C until a
float could be done to confirm the presence
of E.macusaniensis. Oocyst/gram counts
from positive samples were estimated using
the Wisconsin Double-Coverslip method.
Once a positive sample with
sufficient oocysts/gram (15-35+ oocysts/g of
fecal sample) was found, the sample had to
be concentrated down. Multiple protocols,
including various forms of filtration and
solutions (concentrated saline (spg 1.195)
and Sheather’s Sugar without preservative
(spg 1.275)) were explored to find the most
efficient method of E.macusaniensis oocysts
concentration. After numerous
combinations were explored, the following
method proved to be most useful. Samples
(stored in a gallon sized zip lock bag) were
mixed with approximately 1-1.5 liters of
warm tap water. The feces were then
crushed and mixed with the water and let to
sit for 20 minutes. The homogenous
solution was then filtered and strained
through 3 layers of grade #50 cheesecloth
(discard remaining solid). The solution was
then filtered through a standard sieve (#400
38 µm). The solid left behind in the sieve
was washed with distilled water into
multiple 50 ml centrifuge tubes. The

centrifuge tubes were spun at 1500 rpm for 8
minutes and the supernatant was decanted
without disturbing the pellet. The tubes
were then filled back with tap water and respun at the above conditions as a wash until
the supernatant was mostly clear.
Sheather’s sugar solution (spg 1.275)

Figure 2: E.macusaniensis demonstrating four

distinct sporoblasts after 12 days in
Potassium Dichromate

without preservative (Formaldehyde) was
then poured into the tube and mixed with the
pellet. Each tube was then centrifuged again
at the above conditions. The top 3-5 mls of
each tube was suctioned off and poured into
a single 50 ml centrifuge tube, making sure
to not have a single 50 ml tube with more
than 20 mls of supernatant (50 ml tubes with
sugar were saved for a later time). The tube
was then filled with tap water and
centrifuged a final time (1500 rpm for 5
minutes); pouring off the supernatant (the
pellet should now be highly concentrated
with E.macusaniensis oocysts). The tubes in
which the top layer was siphoned off were
then stored at 3-4°C for 3-5 days allowing
time for all E.macusaniensis oocysts to float
to the top. The process was then repeated
starting with the siphoning of the top 3-5
mls of solution. Concentrated E.mac was
then stored in 4% potassium dichromate in
3-4°C until used in sporulation.

Sporulation of E.macusaniensis was
also attempted with various protocols to find
the most efficient method. Most Eimeria
typically sporulate at room temperature in 57 days when mixed with 2.5-4% potassium
dichromate. However, from preliminary
data, it was found that E.macusaniensis
takes approximately 2-4 weeks to reach its
infectious form in the laboratory at the
above conditions. In an attempt to make the
process more efficient, various factors were
changed to decrease sporulation time. Both
2% sulfuric acid and 4% potassium
dichromate were compared in the
sporulation process. Similarly, samples
were tested at both room temperature and at
approximately 27.3 °C (81°F) in an
incubator. Samples were placed into a
beaker with 400 ml of 4% potassium
dichromate (with an escape valve) and
aerated with a constant supply of air from a
fish tank aerator and tubing. During the
sporulation process, water was added to
account for lost water during evaporation.
The sample was checked every few days to
monitor the sporulation process.
Completely sporulated and infectious
E.macusaniensis will be used to re-infect the
llamas to provide a constant supply of
oocysts or will be stored for later use in
vero-cell inoculation.
Results
After multiple attempts at perfecting
the protocols for concentrating and
sporulating E.macusaniensis, a few
procedures appeared more successful than
others. The initial concentration method
attempted with a concentrated saline
solution (spg 1.195) proved to be successful
(Hofmann et al. 1990). However, the
process prevented concentration of large
quantities of feces (limited to 200 grams)
and was inefficient as a mass concentration
method. The method described above, using
a non-preservative form of Sheather’s sugar

(spg 1.275) demonstrated similar success
with the ability to concentrate large
quantities of feces (upwards of 700 grams)
at once. Similarly, the amount of
centrifugation for the second method was
lower. This particular method resulted in a
collected concentration of ~45% (roughly
4,000 oocyts out of an estimated 8,900.) of
the oocysts as determined by the Wisconsin
Double cover-slip method after the first
siphoning. When the 50 ml tubes were
allowed to sit for 3-5 days, the total
collection numbers jumped to 90% of total
estimated oocysts. In order to increase time
and efficiency of this procedure, it is
recommended that the #400 standard sieve
be replaced by a #270 (53 µm) in order to
still ensure collection of E.macusaniensis
(measuring 93.6 µm by 67.4 µm) while
decreasing time length of filtration.
Similar to the concentration
protocols, two protocols for sporulation
were tested. The first used a 2% sulfuric
acid incubated at a temperature of 27.3 °C
(81°F). Multiple cell culture flasks (25cm3)
with positive fecal samples were placed onto
an orbital shaker at 380 rpm. Caps were left
loose in order to allow for an exchange of
oxygen. After 8 days, oocysts started
showing signs of sporulation. Complete
sporulation was observed by day 28.
The method, described in the
material and methods section of this paper,
which used a 4% potassium dichromate
solution instead of 2% hydrochloric acid
demonstrated slightly faster results, showing
compartmentalization by day 7 and
complete sporulation by day 21 of the
process. Similarly, it was found that when
incubated, the solution of potassium
dichromate created less fumes than that of
the hydrochloric acid. Due to the faster
sporulation time and decreased fumes, it is
recommended that the protocol with
potassium dichromate incubated at 27.3 °C
(81°F) be used.

Discussion
Clearly, there is a need to continue
research on this particular NWC parasite.
With little information available on this
specific coccidian, it becomes difficult to
diagnose and treat. This paper, which
reviewed and modified protocols established
for other species of Eimeria, will be used to
lay the foundation for a larger research
project in which sporulated E.macusaniensis
will inoculated into cultured vero-cells to
test the efficacy of various anti-coccidian
drugs. By following the protocols laid out
in the materials and methods section of this
paper, one will be able to locate, concentrate

and sporulate E.macusaniensis in an
efficient and timely manner for use in
further research and study of this coccida.
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